Skip to main content
. 2021 Feb 11;13:1343–1356. doi: 10.2147/CMAR.S287922

Figure 1.

Figure 1

Kaplan–Meier curves demonstrating the impact of AL amyloidosis on overall survival of symptomatic multiple myeloma. (A) Survival difference between symptomatic multiple myeloma patients with and without AL amyloidosis. P=0.023. (B) Survival difference between AL patients (symptomatic multiple myeloma) with and without heart involvement. P=0.024. (C) Survival difference between AL patients (symptomatic multiple myeloma) with and without liver involvement. P=0.013.